Stock Quality:
Trailing 12 Months
-19.5%
EIGR RSI Chart
Growth
Profitability
Size
Dilution Risk
Balance Sheet
Momentum
Funds Popularity
Insider Trading
Historical Charts for Stock Metrics
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2023 | 0 | 15.5M | 14.6M | 14.4M |
| 2022 | 11.2M | 13.2M | 14.1M | 13.5M |
| 2021 | 0 | 0 | 0 | 12.1M |
| CEO | Dr. David Apelian M.B.A., M.D., MBA, Ph.D. |
|---|---|
| WEBSITE | eigerbio.com |
| SECTOR | Healthcare |
| INDUSTRY | Biotechnology |
| EMPLOYEES | 56 |